PLPL Looking Extremely Strong Today, Hitting HOD


Afternoon all,
We alerted you to Plandai Biotechnology, Inc (PLPL) this morning, and so far so good.
PLPL is trading up 5% as I write this email, but was up as much as 7% in the day.
Volume is good, and the supporting bids in PLPL are very strong – which signals pent up demand.
The bullish chart formation is still very much intact with the flag narrowing its range.
We think a breakout is imminent. As you can see on the chart below, a break to the upside through $0.55 will see $0.60 tested. If it can break through this level, the sky is literally the limit.
But the key is to buy before this breakout – in expectation of it, in order to maximize gains and minimize risk.
And there is a great story behind PLPL, the Company, too. If you missed my email this morning, make sure to check it out (I’ve included it below)
I will keep you updated on any new developments on PLPL.

I’ve found a few good potential trades, but one that really stands out.
Plandai Biotechnology, Inc (PLPL)


PLPL has had a nice run in the past couple months, but the biggest move is about to come soon.
We are in a bull market folks. Stocks are running big. 1,000%+ gains are common now. 
Do you want some of these gains?

PLPL has an explosive chart in progress. Take a look below. It has had a solid run thus far, but it has not finished yet.
The chart is "flagging" right now. A flag is a very bullish chart pattern that signals to technical traders that buying demand and selling pressure is in equilibrium after a strong run higher. Usually, a flagging chart is proceeded by a big run higher, often times a parabolic surge.


It is clear that the recent trading range is tight. Support looks to be around $0.48, with resistance around $0.53. A break higher out of this flag formation will mean big gains for PLPL buyers.
The point here is that we must be a buyer of PLPL while its trading in this range, before the inevitable run higher.
This may be a multi-day or multi-week event, not a quick one day play.
PLPL is more than just a chart.
Investors have been excited about PLPL for a while now. And it’s no wonder why, take a look at some of the recent press on PLPL.



MicrosoftInternetExplorer4Plandai Biotechnology (PLPL) intends to
transform the world of nutraceuticals and
is the culmination of over ten
years of research in the field of plant extracts. Its principle holdings
consist of land, farms and infrastructure, totaling more than 8500 acres, in
the province of Mpumalanga,
South Africa

This Seattle based biotechnology firm uses a
proprietary process that is dramatically improving the bioavailability of their
compounds through molecular changes to the live botanicals themselves.

PLPL controls every aspect of the process, from growing
the raw materials on its farms in South Africa, to producing its
patented Phytofare(TM)
extracts in-house, allowing the Company to guarantee the continuity of supply
as well as quality control throughout the entire process. Targeted industries
for the Company’s products include food and beverage, cosmeceutical, wellness,
nutraceutical, anti-aging, and pharmaceutical

==> The Future with PLPL Starts Here <==

What is Phytofare(TM)?

The company’s patented hydrodynamic sheering process through
which live plant-materials are converted at the molecular level during
extraction into a nano-particle structure that mimics that found in human
tissues.  Where most botanical products have less than 10% absorption,
according to the company and documented research,
Phytofare(TM) is clinically
proven to have far superior absorption. 

translates into the
ability for users to receive a
clinical dose with lower quantities.  By definition, when a medication is
administered intravenously, its bioavailability is 100%.  When a
medication is administered in any other way, orally for instance, its
bioavailability generally decreases due to incomplete absorption and may vary
from patient to patient.  Bioavailability can be defined as a measurement
of the amount of any compound to be absorbed into the bloodstream.

In short, PlandaĆ­ takes the
good, removes the bad and amplifies the benefits of nutrients to manufacture
better food and drinks through better technology.  
PLPL has collaborated
with some of the biggest and brightest minds in the food and beverage

=>> In Depth Fact Check on the amazing Plandai Biotechnology <==

According to the Company, PLPL will look to
introduce 3 separately branded extracts that will offer customers the high
bioavailability that its patented technology can provide.

  • Green Tea Catechin Extract
  • Citrus Limonoid Glycoside
  • Carotenoid Botanical Extract
Addressing a number of the
most talked about areas in the industry, these extracts will look to offer
preventative and inhibitive options for:  cancer prevention, anti-viral
protection, anti-inflammation, antioxidants, weight loss, high blood pressure,
and sports injury recovery.
We think a look at PLPL at these levels is a must, in anticipation another strong leg higher.
Remember the general rule. Each move higher is usually stronger than the prior move. 
The next run higher in PLPL, should be bigger than the 200%+ run it made a few weeks ago.

st1\:*{behavior:url(#ieooui) }

/* Style Definitions */
{mso-style-name:"Table Normal";
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
font-family:"Times New Roman";


Click Below to Join Our Social Media Networks




————————————————————————————- DISCLAIMER —————————————————————————————

Never invest in any stock featured on our site or emails unless you can afford
to lose your entire investment.

Full disclaimer can be read at employees are not registered as an Investment Adviser in
any jurisdiction whatsoever.

The disclaimer is to be read and fully understood before using our site, or
joining our email list.

None of the materials or advertisements herein constitute offers or
solicitations to purchase or sell securities of the companies profiled herein
and any decision to invest in any such company or other financial decisions
should not be made based upon the information provide herein.  Instead strongly urges
you conduct a complete and independent investigation of the respective
companies and consideration of all pertinent risks. does not offer such advice or analysis, and further urges
you to consult your own independent tax, business, financial and investment
advisors. Investing in micro-cap and growth securities is highly speculative
and carries and extremely high degree of risk. It is possible that an
investor’s investment may be lost or impaired due to the speculative nature of
the companies profiled.

Any statements that express or involve discussions with respect to predictions,
expectations, beliefs, plans, projections, objectives, goals, assumptions or
future events or performance are not statements of historical fact may be
"forward looking statements". Forward looking statements are based on
expectations, estimates, and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through use of
words such as "projects", "foresee", "expects",
"will", "anticipates", "estimates",
"believes", "understands", or that by statements indicating
certain actions "may", "could", or "might" occur.
Understand there is no guarantee past performance will be indicative of future

In preparing this publication,
has relied upon information supplied by its customers, and press releases which
it believes to be reliable; however, such reliability cannot be guaranteed.
Investors should not rely on the information contained in this website. Rather,
investors should use the information contained in this website as a starting
point for doing additional independent research on the featured companies. The
advertisements in this website are believed to be reliable, however, and its owners,
affiliates, subsidiaries, officers, directors, representatives and agents
disclaim any liability as to the completeness or accuracy of the information
contained in any advertisement and for any omissions of materials facts from
such advertisement.
is not responsible for any claims made by the companies advertised herein. may
receive compensation and its employees and affiliates may own stock that they
have purchased in the open market either prior, during, or after the release of
the companies profile which is an inherent conflict of interest in statements and
opinions and such statements and opinions cannot be considered independent. and its
management may benefit from any increase in the share price of the profiled
companies and hold the right to sell the shares bought at any given time
including shortly after the release of the companies profile. has been compensated two thousand dollars from Cream Consulting for this profile of PLPL.
may on occasion accept compensation in free-trading shares for it’s marketing
services of the company being profiled, and the third party that might have
may hold free-trading shares of the company being profiled and could very well
be selling shares of the companies stock at the same time the profile is being
disseminated to potential investors; this should be viewed as a definite
conflict of interest and as such, the reader should take this into
consideration.  If
ever accepts compensation in the form of free trading shares of the company
being profiled and decides to sell these shares into the public market at any
time before, during, or after the release of the companies profile our
disclaimer will be updated accordingly reflecting the current position of those
free trading shares received as compensation for our services.

/* Style Definitions */
{mso-style-name:"Table Normal";
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";

244 5th Ave, New York, NY 10001

Unsubscribe | Change Subscriber Options